Clinical Trial Update: Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating an umbilical cord blood transplant using fludarabine, melphalan, and anti-thymocyte globulin in patients with hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Neoplasms

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Myeloproliferative Disorders, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2011-08-03